フェンタニル市場レポート：2030年までの動向、予測、競合分析

フェンタニルの動向と予測

世界のフェンタニル市場は、2024年から2030年にかけてCAGR 6.2％で成長すると予測されます。この市場の主な促進要因は、世界の高齢化率の上昇、がん罹患率の増加、腫瘍学への支出の増加です。世界のフェンタニル市場の将来は、病院、腫瘍センター、手術センター市場での機会により有望視されています。

• Lucintel社は、投与経路のカテゴリーでは、経口フィルムが予測期間中に最も高い成長を遂げると予測しています。
• 最終用途カテゴリーでは、がんと診断される患者数の増加により、腫瘍センターが最大のセグメントであり続けると思われます。
• 地域別では、北米が人口の増加と研究努力に加え、多様ながん診断を包含する健康保険により、予測期間中に最も高い成長が見込まれます。

フェンタニル市場の戦略的成長機会

フェンタニル市場には、薬物投与における技術の進歩、ヘルスケア要件の変化、業界の規則や規制の変化などを原動力とする、さまざまな用途にわたるいくつかの戦略的成長機会があります。フェンタニルの使用に関連する課題に対処しながら、このマーケットプレース内の動向を活用したいと考える利害関係者は、これらの動向を正しく見極め、それを適切に活用することが重要です。

• 乱用抑止製剤の開発：フェンタニル市場の成長は、乱用抑止製剤の開発によって大きく拡大する可能性があります。これらの製剤は、薬物への干渉や乱用を困難にすることで、誤用や中毒を減らすために作られます。例えば、徐放性パッチや、フェンタニルが疼痛治療に有効であることを保証しながらナロキソンを配合した製品などを開発することができます。このような製剤への注目は、規制の動向に沿ったものであり、オピオイド乱用への懸念を認識したものです。
• 疼痛管理ソリューションの拡大：疼痛管理ソリューションの拡大は、フェンタニル市場の主要な成長分野の1つを形成しています。効率的な疼痛管理に対する需要が増加していることから、効率性と安全性の向上を保証する高度なフェンタニル製剤と送達システムが必要とされています。そのため、企業はヘルスケア提供者の要求に沿って、個別化された疼痛管理計画や、異なる患者カテゴリーをターゲットとした併用薬などの他の用途に進出する可能性があります。この成長機会は、患者の転帰を改善し慢性疼痛を管理することへの関心が高まっていることと一致しています。
• ナロキソンへのアクセスの増加：ナロキソンへのアクセスの拡大は、フェンタニル市場において戦略的な成長機会となります。ナロキソン（過剰摂取を回復させるためのオピオイド拮抗薬）の入手可能性を拡大することは、オピオイド危機が世界的に地域社会に影響を与え続けており、収束の見通しが立っていないことから必要です。今日の世界では、今後この問題に対処するためのより良い備えが求められています。その結果、企業はナロキソンを広く配布することを目的としたプログラムにもっと投資することができると思われます。公衆衛生機関との提携や、この製品をより入手しやすくするための斬新な方法は、この成長段階への参入を促進し、関連する保健イニシアティブは、過剰摂取をより効果的に防止する手段を生み出すと思われます。
• 新興市場の成長：フェンタニル市場には、新興国市場の急速な開拓による大きなチャンスがあります。特にアジア太平洋地域やラテンアメリカでは、疼痛管理に対する人々の意識が高まるにつれ、ヘルスケア・インフラが改善し、フェンタニルやその他のオピオイドに対する需要が高まる。企業は、流通チャネルを構築し、製品をローカライズし、規制の枠組みを理解することで、これらの市場に進出することができます。この成長機会は、急速に発展している地域における収益と市場プレゼンスを高める可能性を秘めています。
• デジタル・ヘルス・ソリューションの進歩：フェンタニル市場には、デジタル・ヘルス・ソリューションの開発による成長機会が存在します。遠隔医療、モバイルヘルスアプリ、モニタリングシステムなどのデジタル技術の統合により、疼痛管理とオピオイド管理が強化される可能性があります。これらの技術は、特定のケアサービスの提供、患者の服薬率の向上、治療後の患者の転帰の追跡に利用できます。この成長機会は、デジタルヘルスに向かう傾向が強まっていることと一致しており、フェンタニルの使用管理におけるイノベーションの可能性を提供するものです。

イノベーションを促進し、市場範囲を拡大し、進化するヘルスケアニーズに対応することで、これらの戦略的成長機会はフェンタニル市場の展望を再構築しています。フェンタニルに関連する疼痛管理の問題に対処することを目的とした、より安全で効果的な治療薬の創出を支援することで、企業は競合優位性を獲得することができます。

フェンタニル市場の促進要因・課題

フェンタニル市場は、その成長と開拓を形作る様々な促進要因・課題の影響を受けています。主な促進要因には、技術の進歩、経済要因、規制の変更などがあり、一方、重大な課題には、規制の遵守、市場内の競争、使用材料に関連する制限などがあります。この複雑な薬剤クラス別取引の利害関係者にとって、これらのダイナミクスを理解することは重要です。

フェンタニル市場を牽引する要因には、以下のようなものがある：

1.技術の進歩：フェンタニル市場の成長は主に技術開拓別もたらされます。乱用抑止製剤や徐放パッチなどのドラッグデリバリーシステムの革新は、フェンタニルの安全性と有効性を向上させる。これらの進歩は、患者の疼痛管理を強化すると同時に、中毒症例や誤用を軽減することを目的としています。技術に投資する企業は、差別化された製品を提供することで、ダイナミックな市場動向に適応し、フェンタニル市場における競争優位性を獲得することができます。

2.疼痛管理に対する需要の増加：疼痛管理の需要が大幅に増加しており、フェンタニル市場を牽引しています。慢性疼痛疾患の有病率の増加に伴い、フェンタニルのような疼痛緩和のための効果的なソリューションが必要とされています。このような需要の背景には、60歳以上の人口の増加、医療治療法の進歩、さまざまな疼痛管理戦略に対する認識などがあります。その結果、疼痛コントロールの必要性の高まりとともにフェンタニルのニーズが高まり、市場規模の拡大に寄与しています。

3.安全使用のための規制支援：フェンタニルの安全な使用に関して、世界中のさまざまな政府で規制当局別支援が認められており、マーケットプレース内での拡大につながっています。例えば、新しい形態の医薬品を承認したり、一般的な年単位または月単位で処方実務を監視したりすることでこれを実施しています。このような規制は、最終的に中毒につながる乱用から市民を守ることを保証すると同時に、医学的に必要なときにはいつでも医師がフェンタニルを入手できるようにします。安全な使用の観点から、これらの政策は、オピオイド危機への対応と患者ケアの向上を目指したより広範な取り組みと一致しています。

4.ヘルスケアへのアクセスの拡大：世界のヘルスケアセクターの成長率は、フェンタニルに関連するものも含め、この産業内の細分化された部門全体の売上を推進する主要な原動力の1つとして浮上している（Tyler et al.）その結果、世界のヘルスケア施設の増加は、特にフェンタニルを含む様々な種類の疼痛管理を受けられる患者の増加を意味します。このような拡大は、ヘルスケアへのアクセスが向上し、人々がオピオイド薬の必要性についてより多くの情報を得るようになったため、主に新興市場で起こっています。ヘルスケアへのアクセスの拡大は、フェンタニルの幅広い普及に寄与し、市場開拓を支えています。

5.公衆衛生への取り組みの重視：公衆衛生への取り組みは、フェンタニル市場に大きな影響を与えています。例えば、ナロキソンの適用範囲拡大や有害物質削減プログラムなどの施策は、この業界の再形成において重要な役割を果たしています。主にこれらのイニシアチブは、患者の回復率を向上させながら、オピオイドの使用に伴う悪影響を最小限に抑えることを目的としています。このような取り組みに企業が関与することで、市場内での存在感を高めつつ、全体的な健康目標に沿うことができます。

フェンタニル市場における課題は以下のとおりである：

1.規制の遵守：規制の遵守は、フェンタニル市場で事業を展開する企業にとって重要な課題です。このため、製品の有効性と安全性を確保するための厳格な規則やガイドラインを遵守する必要があります。絶え間なく変化する規制を確実に遵守することは、非常に困難でコストがかかり、製品開拓プロセスを複雑にし、特定の市場へのアクセスを制限する可能性があります。法的問題を回避するために、企業は規制に関する専門知識を持ち、市場シェアを維持するために、製品が適用されるすべての基準に合致していることを確認しなければならないです。

2.市場競争：フェンタニルの分野では、高い競合レベルが企業が直面する大きな課題の一つです。類似製品を製造するさまざまな企業が大きな競争を生み出し、価格下落圧力につながります。したがって、企業は競争力を維持するために、強力なマーケティング戦略と相まって、高品質な製品を生み出す革新的なアイデアを開発しなければならないです。これらの競合に対処することは、将来の世界な顧客基盤の拡大や現在の市場での成功を目指す企業にとって不可欠です。

3.材料の限界：フェンタニル製品の性能は、材料の制約や特定の製剤の効率性・安全性などの要因に左右されます。このような製品の成功を制限する可能性のある課題には、限られた有効性、潜在的な副作用、長期にわたる鎮痛効果の課題などがあります。これらの制約を克服するためには、製品の品質を向上させ、顧客の期待に応えるための研究開発が企業別実施されなければならないです。

業界の複雑さは、フェンタニル市場に影響を与える促進要因・課題によって浮き彫りにされています。技術の進歩、疼痛管理に対する需要の増加、規制上の支援が成長を促進する一方で、規制遵守、市場競争、材料の制限が大きな課題となります。フェンタニル分野の企業は、この業界で長期的に成功するために、これらの要因に対処するよう努めるべきです。

目次

第1章 エグゼクティブサマリー

第2章 世界のフェンタニル市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のフェンタニル市場の動向（2018～2023年）と予測（2024～2030年）
• 投与経路別：フェンタニルの世界市場
  • 舌下錠
  • バッカル錠
  • 口腔フィルム
  • その他
• 最終用途別：フェンタニルの世界市場
  • 病院
  • 腫瘍学センター
  • 外科センター
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別フェンタニルの世界市場
• 北米のフェンタニル市場
• 欧州のフェンタニル市場
• アジア太平洋地域のフェンタニル市場
• その他地域のフェンタニル市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 投与経路別：世界のフェンタニル市場の成長機会
  • 最終用途別：世界のフェンタニル市場の成長機会
  • 地域別：世界のフェンタニル市場の成長機会
• 世界のフェンタニル市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のフェンタニル市場の生産能力拡大
  • 世界のフェンタニル市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Bayer
• Novartis
• Sanofi-Aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries

Fentanyl Trends and Forecast

The future of the global fentanyl market looks promising with opportunities in the hospital, oncology center, and surgical center markets. The global fentanyl market is expected to grow with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are the rising aging population globally, increasing incidences of cancer, and rising oncology spending.

• Lucintel forecasts that, within the route of administration category, oral film is expected to witness the highest growth over the forecast period.
• Within the end-use category, the oncology center will remain the largest segment due to the rising number of individuals diagnosed with cancer.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to increasing population and research endeavors, coupled with health insurance encompassing diverse cancer diagnoses.

Gain valuable insight for your business decisions with our comprehensive 150+ page report

Emerging Trends in the Fentanyl Market

Several emerging trends in the fentanyl market are indicative of larger regulatory, technological, and social shifts. How fentanyl is developed, distributed, and managed is being shaped by these patterns, which also have significant implications for both medical and illicit use. Grasping these developments becomes vital for stakeholders who wish to navigate this shifting landscape of fentanyl markets.

• Enhanced Regulatory Measures: Increasing concerns regarding addiction and misuse are driving enhanced regulatory measures within the fentanyl market. The opioid crisis has led governments around the world to tighten control over the production, distribution, and prescription of fentanyl. These measures include stricter prescription practices, better tracking systems, and sterner penalties against illegal trafficking. Such steps aim to strike a balance between effective pain management on one hand and the prevention of misuse leading to abuse on the other.
• Innovations in Drug Delivery Systems: The fentanyl market is being transformed through innovations in drug delivery systems. For instance, extended-release patches and abuse-deterrent formulations under development are expected to increase safety levels and effectiveness of new fentanyl products. These advances reduce addiction risks while simultaneously improving pain management among patients. Thus, changes in drug delivery technology are expected to significantly influence the future dynamics of fentanyl treatment and its market.
• Growing Focus on Naloxone Availability: There is an increasing emphasis on boosting naloxone availability (an opioid antagonist used to reverse overdoses). This expansion addresses several issues related to opioids, particularly counterfeit drugs made from fentanyl, by responding to the ongoing global opioid crisis. Public health programs are implementing policies to introduce naloxone to first responders, including healthcare providers and those at risk of overdose, making it more accessible. This matters since it can address public health impacts associated with opioid use beyond just those caused by fentanyl.
• Expansion of Harm Reduction Strategies: Harm reduction strategies are becoming more prevalent in the fentanyl market as part of a broader approach to addressing the opioid crisis. These measures include using fentanyl testing strips, supervised injection facilities, and needle exchanges. The aim is to reduce the adverse health outcomes associated with opioid use, including that involving fentanyl, and to provide assistance and resources for people fighting addiction. Thus, by expanding harm reduction strategies, we can see a shift towards more compassionate, public health-focused approaches.
• Increased International Collaboration: Notably, there is increased international collaboration in the fentanyl market. Countries are partnering to address global threats arising from fentanyl and other synthetic opioids. This involves sharing intelligence on trafficking networks, harmonizing regulatory frameworks, and coordinating public health responses, among other actions. International cooperation is essential to effectively address the complications associated with fentanyl, ensuring effective management of its use and prevention of abuse.

These emerging trends have changed the face of the fentanyl market through regulatory practices, technological innovations, and public health approaches. Therefore, stakeholders need to adjust accordingly, as these trends will help them meet the challenges they face in dealing with fentanyl in society today, which is continually evolving.

Recent Developments in the Fentanyl Market

Technological advances, policy changes, and healthcare reforms have all played a major role in the recent developments witnessed in the fentanyl market. They are changing how fentanyl is used for medical purposes and its contribution to the opioid epidemic. Understanding these critical developments helps us understand how this market has been responding to new challenges and opportunities.

• The New Stringent Regulation Rules: Governments from around the world are introducing stricter regulations on fentanyl as part of efforts aimed at fighting the opioid crisis. This includes tightening prescription regulations, increasing monitoring of prescribing practices, and imposing stiffer penalties for illegal trafficking of such drugs. These measures aim to reduce misuse and abuse while ensuring that fentanyl remains available for legitimate medical use. Stricter controls also influence market dynamics regarding the prescribing and distribution of fentanyl.
• Introduction of Abuse-Proof Formulations: The introduction of abuse-resistant formulations is a major development seen in the fentanyl market. These formulations aim to make it more difficult for people to tamper with or abuse fentanyl, thus reducing the chances of addiction or misuse. Examples include extended-release patches and naloxone combination products, which have been introduced to ensure the safe use of fentanyl while still serving as effective painkillers. These trends will shape future usage patterns associated with fentanyl and alleviate concerns regarding opioid dependency issues.
• Expansion of Harm Reduction Initiatives: As part of a broader strategy to address the opioid crisis, harm reduction initiatives are increasing. They include wider use of naloxone, employing fentanyl test strips, and establishing supervised injection sites, such as in Vancouver, where about 4 million prescriptions were written last year alone (Syringe Distribution Program). Such initiatives aim to mitigate risks connected with opioids, including those containing fentanyl, while also supporting those struggling with addiction and related problems. Increasingly, harm reduction is adopting a comprehensive approach to managing opioid-related concerns.
• International Cooperation as a Priority: International cooperation in the fentanyl market is becoming more important as countries strive to address the global challenges posed by synthetic opioids. Their joint efforts include sharing information about trafficking networks, harmonizing regulatory approaches, and synchronizing public health systems, among others. An increased focus on international cooperation is indispensable given the complexities associated with fentanyl and the need for effective strategies for its management and control.
• Innovations in Pain Management Research: The market for fentanyl is influenced by pain management research, which explores new indications and formulations for the drug. The goal of these studies is to improve efficacy and safety through fentanyl's use in pain management, as well as to find alternatives such as novel delivery systems or combination therapies that could be employed alongside it. These efforts seek to improve patient outcomes by addressing the challenges posed by opioids. Continued emphasis on R&D is fostering innovation in the fentanyl market, leading to better results in pain management.

Consequently, these recent developments have influenced regulatory practices, technological innovations, and public health strategies shaping the fentanyl market. Stakeholders must therefore navigate these transformations, even if the price may be too high, considering how this substance has affected our community today.

Strategic Growth Opportunities for Fentanyl Market

The fentanyl market has several strategic growth opportunities across various applications driven by technological advancements in drug administration, changing healthcare requirements, and shifts in industry rules and regulations. It is important for stakeholders who want to take advantage of trends within this marketplace while dealing with challenges associated with fentanyl usage to identify these trends correctly and capitalize on them appropriately.

• Abuse-Deterrent Formulations Development: Fentanyl market growth can be greatly expanded through the development of abuse-deterrent formulations. These formulations are created to reduce misuse and addiction by making it harder for the drug to be interfered with or abused. For example, companies can develop products such as extended-release patches and those that combine naloxone while ensuring that fentanyl remains effective in pain treatment. The focus on such formulations aligns with regulatory trends and acknowledges concerns about opioid abuse.
• Pain Management Solutions Expansion: The expansion of pain management solutions forms one of the key areas of growth in the fentanyl market. Given the increasing demand for efficient pain management, there is a need for advanced fentanyl formulations and delivery systems that guarantee enhanced efficiency and safety. Hence, businesses could delve into other applications like personalized pain management plans and combined medications targeting different patient categories, in line with healthcare providers' requirements. This growth opportunity aligns with the increasing focus on improving patient outcomes and managing chronic pain.
• More Naloxone Access: Increased access to naloxone offers a strategic growth opportunity within the fentanyl market. Expanding the availability of naloxone (an opioid antagonist used for reversing overdoses) is necessary because the opioid crisis continues to affect communities globally, with no relief in sight. Today's world requires better preparedness to deal with this problem going forward. Consequently, companies could invest more in programs aimed at distributing naloxone widely; partnerships with public health organizations and novel methods to make this product more accessible would facilitate entry into this growth stage, where associated health initiatives will create a means for preventing overdoses more effectively.
• Emerging Markets Growth: The fentanyl market has great opportunities due to the rapid development rates of emerging markets. As awareness of pain management increases among people, especially across Asia-Pacific regions and Latin America, the healthcare infrastructure will improve, leading to greater demand for fentanyl and other opioids. Businesses can expand into these markets by creating distribution channels, localizing products, and understanding regulatory frameworks. This growth opportunity offers potential for increased revenue and market presence in rapidly developing regions.
• Digital Health Solutions Advancements: Growth opportunities exist in the fentanyl market through the development of digital health solutions. The integration of digital technologies such as telemedicine, mobile health apps, and monitoring systems could enhance pain management and opioid control. These technologies can be used to offer specific care services, improve medication adherence rates among patients, and track patient outcomes after treatment. This growth opportunity aligns with the increasing trend towards digital health and offers potential for innovation in the management of fentanyl use.

By fostering innovation, expanding market reach, and meeting evolving healthcare needs, these strategic growth opportunities are reshaping the fentanyl market landscape. They can help companies gain a competitive advantage by supporting the creation of safer and more effective remedies aimed at addressing pain management issues related to fentanyl.

Fentanyl Market Driver and Challenges

The fentanyl market is influenced by various drivers and challenges that shape its growth and development. Key drivers include technological advancements, economic factors, and regulatory changes, whereas significant challenges consist of compliance with regulations, competition within markets, and limitations associated with materials used. For stakeholders within the complex field of this drug class trade, it's important to understand these dynamics.

The factors responsible for driving the fentanyl market include:

1. Technological Advancements: Fentanyl market growth is mainly driven by technological developments. Innovations in drug delivery systems, such as abuse-deterrent formulations and extended-release patches, improve the safety and effectiveness of fentanyl. These advances aim to mitigate addiction cases and misuse while also enhancing pain management among patients. Companies that invest in technology will be able to offer differentiated products, thereby adjusting to dynamic market trends and gaining a competitive advantage within the fentanyl market.

2. Increasing Demand for Pain Management: There is a significant rise in demand for pain management driving the fentanyl market. With the increased prevalence of chronic pain conditions, there is a need for effective solutions for pain relief, such as fentanyl. Factors behind this demand include an increase in the population aged over 60 years, advancements in medical treatment methods, and awareness of different pain management strategies. As a result, the need for fentanyl grows with the increasing requirement for pain control, contributing to the expansion of the market size.

3. Regulatory Support for Safe Use: Regulatory support has been recognized across various governments worldwide regarding the safe use of fentanyl, leading to its expansion within the marketplace. For instance, they do this by approving new forms of drugs and monitoring prescription practices on a typical yearly or monthly basis. Such regulations assure citizens of protection from abuse, which ultimately leads to addiction, while ensuring that doctors still have access to it whenever it's medically needed. In the context of safe use, these policies coincide with broader efforts aimed at addressing the opioid crisis and improving patient care.

4. Expansion of Access to Healthcare: The growth rate of the global healthcare sector has emerged as one of the principal drivers propelling sales across subdivisions within this industry, including those relating to fentanyl (Tyler et al., 2016). Consequently, increasing healthcare facilities globally signify that there are more patients who can receive various types of pain management, especially involving fentanyl. This expansion is mainly taking place in emerging markets as accessibility to healthcare improves and people become more informed regarding the need for opioid drugs. The growth in healthcare access contributes to the broader adoption of fentanyl and supports market development.

5. Focus on Public Health Initiatives: Public health initiatives have greatly impacted the fentanyl market. For example, measures such as increasing naloxone coverage and harm reduction programs have played a critical role in reshaping this industry. Primarily, these initiatives aim to minimize the negative implications that come with opioid use while improving patient recovery rates. The involvement of business enterprises with such initiatives can enhance their presence within the market while aligning with overall health goals.

Challenges in the fentanyl market include:

1. Regulatory Compliance: Regulatory compliance is a significant challenge for players operating within the fentanyl market. This requires adherence to a number of strict rules and guidelines meant to ensure product effectiveness and safety. Ensuring compliance with constantly changing regulations can be very difficult and expensive, complicating product development processes and limiting access to particular markets. To avoid legal issues, companies must possess regulatory expertise and ensure their products align with all applicable standards to maintain market share.

2. Market Competition: In the fentanyl sector, high competition levels are one of the major challenges that firms face. Different companies manufacturing similar products generate significant competition, leading to downward pressure on prices. Firms must therefore develop innovative ideas resulting in quality products coupled with strong marketing strategies to remain competitive. Addressing these competitive forces is essential for any firm looking to expand its future global customer base or succeed within its current markets.

3. Material Limitations: The performance of fentanyl products depends on factors such as material constraints and the efficiency and safety of specific formulations. Issues that can limit the success of such products include limited effectiveness, potential side effects, and challenges with long-lasting pain relief. Research and development must be conducted by businesses to improve product quality and meet customer expectations in order to overcome these limitations.

The complexity of the industry is highlighted by the drivers and challenges affecting the fentanyl market. Technological advancements, increasing demand for pain management, and regulatory support drive growth, while regulatory compliance, market competition, and material limitations pose significant challenges. Companies in the fentanyl sector should endeavor to address these factors for long-term success in this industry.

List of Fentanyl Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fentanyl companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fentanyl companies profiled in this report include-

• Bayer
• Novartis
• Sanofi-Aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries

Fentanyl by Segment

The study includes a forecast for the global fentanyl by route of administration, end use, and region.

Fentanyl Market by Route of Administration [Analysis by Value from 2018 to 2030]:

• Sublingual Tablet
• Buccal Tablet
• Oral Film
• Others

Fentanyl Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospital
• Oncology Centers
• Surgical Centers
• Others

Fentanyl Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Fentanyl Market

The fentanyl market is changing significantly as regulation evolves, demand for pain management increases, and drug abuse and trafficking continue to pose challenges. Fentanyl is a powerful synthetic opioid that plays a vital role in medical practice and illicit use. Market trends are responding to policy changes, innovations in drug delivery systems, and strategies aimed at addressing the ongoing opioid crisis. This knowledge is important as it will help stakeholders navigate the complexities of the fentanyl market across various regions.

• United States: Fentanyl in the U.S. market is significantly affected by the opioid epidemic, which has attracted massive regulatory reforms and public health interventions. Recently, there has been stricter regulation on prescription opioids, along with increased efforts against illegal fentanyl trafficking. New formulations of fentanyl have been approved by the U.S. FDA to improve their safety profile and limit the potential for misuse. Moreover, significant attention has been given to naloxone access programs and other harm reduction initiatives for reversing overdose cases. Similarly, the availability of fentanyl test strips for detecting this substance in illegal drugs is being expanded.
• China: China has played a significant role in the production and control of supply chain networks for this narcotic and its analogs within the global market. Recently, the Chinese government has made greater efforts to control the production and export of fentanyl products. In response to international pressure, China tightened regulations on this product while enacting law enforcement measures aimed at curbing illicit trafficking of fentanyl substances globally. Other endeavors also exist to address worldwide concerns surrounding synthetic opioids regarding public health and safety.
• Germany: Germany's steps toward increasing awareness about safe opioid use have seen some progress within their evolving fentanyl market. Recent developments include more controlled formulations of fentanyl, aimed at reducing addictive tendencies among users or abusers. Regulatory bodies in Germany are focusing on advocating for safe utilization mechanisms of these products, especially in cancer pain control. Among the various measures within Germany, there is a wider European initiative for collaborative regulation and public health to monitor and manage opioid use, including fentanyl.
• India: The fentanyl market in India is changing due to various problems associated with drug abuse (both medical and illicit). For instance, efforts have been made to strengthen regulations on the prescription and dispensing of fentanyl due to addiction concerns. The Indian government has embarked on tougher rules for opioids while improving drug enforcement systems. In addition, healthcare providers are being educated about fentanyl risks and patient monitoring behaviors that can reduce tendencies for misuse or dependence.
• Japan: The Japanese fentanyl market is characterized by stringent regulatory oversight and careful attitudes toward opioids. Notably, recent developments include the approval of new formulations of fentanyl designed for improved pain management with reduced addictive properties. Furthermore, efforts to intercept synthetic opioids before they reach the wrong hands have also intensified in Japan. Working closely with medical professionals, the government has sought ways to regulate fentanyl use among patients, thereby avoiding potential misuse or overdose incidents.

Features of the Global Fentanyl Market

Market Size Estimates: Fentanyl market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fentanyl market size by route of administration, end use, and region in terms of value ($B).

Regional Analysis: Fentanyl market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, end use, and regions for the fentanyl market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fentanyl market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the fentanyl market by route of administration (sublingual tablet, buccal tablet, oral film, and others ), end use (hospital, oncology centers, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fentanyl Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Fentanyl Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Fentanyl Market by Route of Administration
  • 3.3.1: Sublingual Tablet
  • 3.3.2: Buccal Tablet
  • 3.3.3: Oral Film
  • 3.3.4: Others
• 3.4: Global Fentanyl Market by End Use
  • 3.4.1: Hospital
  • 3.4.2: Oncology Centers
  • 3.4.3: Surgical Centers
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Fentanyl Market by Region
• 4.2: North American Fentanyl Market
  • 4.2.1: North American Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.2.2: North American Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.3: European Fentanyl Market
  • 4.3.1: European Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.3.2: European Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.4: APAC Fentanyl Market
  • 4.4.1: APAC Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.4.2: APAC Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.5: ROW Fentanyl Market
  • 4.5.1: ROW Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.5.2: ROW Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Fentanyl Market by Route of Administration
  • 6.1.2: Growth Opportunities for the Global Fentanyl Market by End Use
  • 6.1.3: Growth Opportunities for the Global Fentanyl Market by Region
• 6.2: Emerging Trends in the Global Fentanyl Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Fentanyl Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fentanyl Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: Novartis
• 7.3: Sanofi-Aventis Groupe
• 7.4: Abbott Laboratories
• 7.5: Merck & Co
• 7.6: Validus Pharmaceuticals
• 7.7: Teva Pharmaceutical Industries